|
Match
|
Document |
Document Title |
|
|
7414136 |
Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt
To provide a method for producing a 3-substituted 2-chloro-5-fluoro-pyridine or its salt in high yield from a readily available material through a short process under mild reaction conditions using...
|
|
|
7320993 |
Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents
The invention relates to new pyridylalkane, alkene, and alkine acid amides substituted with an aryl and/or heteroaryl residue according to the general formula (I), with a saturated or one or...
|
|
|
7247645 |
Dihydropyridine derivatives
Compounds having a selective N-type calcium channel antagonistic activity are provided. Dihydropyridine derivatives represented by the following formula:
analogs thereof and pharmaceutically...
|
|
|
7199140 |
Vinyl phenyl derivatives as GLK activators
The invention relates to novel compounds of Formula (I) or a salt, solvate or prodrug thereof, wherein A, R 1 , R 2 , R 3 , n and m are described in the specification, useful in the treatment of
...
|
|
|
6995179 |
Dihydropyridine derivative
Dihydropyridine derivatives of the following formula, analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel....
|
|
|
6992095 |
Stilbene compounds comprising an adamantyl group, compositions and methods thereof
The invention relates to novel stilbene compounds having the general formula (I):
as well as to pharmaceutical compositions for use in human or veterinary medicine, including dermatological,...
|
|
|
6951877 |
Materials and methods for treating hypercholesterolemia
The subject invention provides novel HMG-CoA-reductase inhibitors. In a preferred embodiment, the HMG-CoA reductase inhibitors of the subject invention can be deactivated to a primary inactive...
|
|
|
6900232 |
Cycloalkyl alkanoic acids as integrin receptor antagonists
The present invention relates to a class of compounds represented by the Formula I
Wherein A 1 is a pyridinyl of the formula
optionally substituted by one or more R k selected from the...
|
|
|
6727237 |
Inhibitors of bacterial NAD synthetase
The present invention provides methods of synthesizing and screening inhibitors of bacterial NAD synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections...
|
|
|
6713467 |
Acid derivatives useful as serine protease inhibitors
Compounds of formula I and II, or pharmaceutically-acceptable salts thereof, are useful as inhibitors of Factor VIIa, Factor IXa, Factor Xa, Factor FXIa, tryptase, and urokinase, wherein ring B...
|
|
|
6703509 |
Method for producing 5-aryl nicotinaldehydes
The invention relates to a process for the preparation of 5-arylnicotinaldehydes by reduction of the corresponding 5-arylnicotinic acids by catalytic hydrogenation in the presence of carboxylic...
|
|
|
6673938 |
Substituted pyridine herbicides
Compounds of formula (I), in which the substituents are as defined in claim 1 and the agrochemically tolerated salts M+ and all stereoisomers and tautomers of the compounds of formula (I) are...
|
|
|
6649767 |
Process for preparing 1,4-dihydropyridine compounds
A process for preparing a 1,4-dihydropyridine compound comprising contacting an enamine compound and a compound having a structure of in the presence of a base; and treating the reaction...
|
|
|
6541640 |
Process for the preparation of 4-haloalkylnicotinonitriles
4-Haloalkylnicotinonitriles having the formula (I) which are suitable as intermediates in the preparation of pesticides, are obtained by: (a) reacting a 3-amino-1-haloalkyl-2-propen-1-one R F...
|
|
|
6515023 |
Thrombin receptor antagonists
A thrombin receptor antagonist having the formula useful for inhibiting the aggregation of blood platelets. The compounds can be used in a method of acting upon a thrombin receptor which...
|
|
|
6500852 |
Inhibitors of bacterial NAD synthetase
The present invention provides methods of synthesizing and screening inhibitors of bacterial NAD synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections...
|
|
|
6489347 |
Process
Compounds of structure (1) are obtained by reduction of compounds of the structures Compounds of structure (1), especially where Z is a hydrogen atom or a 3,4-methylenedioxyphenyl group, are...
|
|
|
6441182 |
Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
The invention relates to a method for the production of 2,6-dichloro-5-fluoronicotinic acid by hydrolyzing 2,6-dichloro-5-fluoro-3-cyanopyridine by (a) dissolving...
|
|
|
6441010 |
Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them
Bi-aromatic compounds linked via a heteroethynylene radical are provided along with pharmaceutical and cosmetic compositions containing these compounds and methods for their use.
|
|
|
6432960 |
Squarate derivatives of dihydropyridine NPY antagonists
A series of antagonists of NPY have been synthesized and are comprised of squarate derivatives of 4-phenyl-1,4-dihydropyridines of Formula (I). As antagonists of NPY-induced behavior, these...
|
|
|
6392050 |
Process for preparing substituted pyridines
The invention relates to a process for preparing substituted pyridines in a simple and cost-effective manner in good yields by reacting substituted 1,4-dihydropyridines with methyl nitrite in the...
|
|
|
6391881 |
Thiourea derivatives of dihydropyridine NPY antagonists
A series of antagonists of NPY have been synthesized and are comprised of thiourea linked piperazine and piperidine derivatives of 4-phenyl-1,4-dihydropyridines of Formula 1. where Z is NR 7 R 8...
|
|
|
6376521 |
A3 adenosine receptor antagonists
Disclosed are pyridine and dihydropyridine derivatives, pharmaceutical compositions comprising one or more of these derivatives, and a method of selectively blocking an A 3 adenosine receptor of a...
|
|
|
6344561 |
O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
Compounds of the formula where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity.
|
|
|
6310214 |
Process for the preparation of chloropyridine sulphonic acid chlorides
A process is disclosed for preparing chlorinated pyridinesulphonic acid chlorides of the general formula I ##STR1## from hydroxypyridine-sulphonic acids of the general formula II ##STR2## The...
|
|
|
6214878 |
Stilbene compounds comprising an adamantyl group, compositions and methods thereof
The invention relates to novel stilbene compounds having the general formula (I): ##STR1## as well as to pharmaceutical compositions for use in human or veterinary medicine, including...
|
|
|
6165236 |
Poly(oxyalkylene) pyridyl and piperidyl esters and fuel compositions containing the same
A poly(oxyalkylene)pyridyl or piperidyl ester having the formula: ##STR1## or a fuel-soluble salt thereof; wherein A is a nitrogen-containing ring selected from the group consisting of 3-pyridyl,...
|
|
|
6110970 |
Nitrogen-containing oxyalkylene esters and uses thereof
This invention relates to nitrogen-containing oxyalkylene diester compositions for treating disease conditions including cancer and other proliferative diseases. The nitrogen-containing oxyalkylene...
|
|
|
6090824 |
Therapeutic neurokinin receptor antagonist compounds
Compounds of formula I ##STR1## wherein Q 1 , Q 2 , Q 3 , and Q 4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide...
|
|
|
6045720 |
Pyridine compound and liquid crystalline composition
A compound expressed by the following formula (1) and a liquid crystalline composition with using it are provided: ##STR1## wherein, either one of rings A, B and C denotes ##STR2## remaining two of...
|
|
|
6022974 |
Process for the production of 2-chloro-5-chloromethyl-pyridine
A process for the production of 2-chloro-5-chloromethylpyridine of the formula: ##STR1## starting from 6-hydroxynicotinic acid of the formula: ##STR2## In this way 6-hydroxynicotinic acid is...
|
|
|
5919792 |
Integrin antagonists
This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as vitronectin receptor antagonists. The vitronectin receptor antagonist compounds of the...
|
|
|
5892050 |
Process for the preparation of pyridine dicarboxylate derivatives
There is provided a single vessel process for the preparation of a pyridine dicarboxylate compound of formula I ##STR1## via the sequential condensation of an alkyl vinyl ether with Vilsmeier...
|
|
|
5869676 |
Process for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP
The present invention relates to improved, efficient chemical syntheses of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and 3-amino-4-methylpyridine-2-carboxaldehyde thiosemicarbazone...
|
|
|
5861419 |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic...
|
|
|
5747422 |
Substituted 2-phenylpiridines
Substituted 2-phenylpyridines I ##STR1## where substituents have the meaning described in the specification and their use as herbicides; for the desiccation/defoliation of plants.
|
|
|
5739342 |
Process for the preparation of nicotinic acids
The present invention relates to an improved process for the preparation of nicotinic acids represented by the following structural formula (I): ##STR1## which are prepared by reacting a nicotinic...
|
|
|
5716971 |
Pyridine derivatives, their production and use
Pyridine derivatives of the formula ##STR1## wherein the ring A stands for an optionally further substituted benzene ring; the ring B stands for an optionally substituted pyridine ring; Q stands...
|
|
|
5708175 |
Process for producing 4-trifluoromethylnicotinic acid
A process for producing 4-trifluoromethylnicotinic acid of the formula (VIII) or its salt: ##STR1## which comprises (i) a first step of reacting a halide of the formula (I): CF 3 COHal ...
|
|
|
5691366 |
Nitro compounds, process for preparation thereof and use thereof
A new nitro compound of the formula: ##STR1## wherein R 1 and R 2 are each lower alkyl or lower alkoxy(lower)-alkyl, or ##STR2## is cyclized to form ##STR3## X is --O--, --S-- or --NH--, m is an...
|
|
|
5659042 |
Method for preparing esters of halonicotinic acids
The present invention provides a method of preparation of ethyl 6-halonicotinate, wherein said halo is chloro or iodo, which comprises reacting the 6-halonicotinic acid with triethyl orthoacetate,...
|
|
|
5605915 |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
Compounds of the formula ##STR1## wherein the symbols have the meaning defined in the specification.
|
|
|
5604227 |
Pyridazinedione compounds useful in treating neurological disorders
The present invention relates to pyridazino[4,5-b]quinolines, and pharmaceutically useful salts thereof, which are excitatory amino acid antagonists and which are useful when such antagonism is...
|
|
|
5599814 |
Pyridazinedione compounds useful in treating neurological disorders
The present invention relates to pyridazino[4,5-b]quinolines, and pharmaceutically useful salts thereof, which are excitatory amino acid antagonists and which are useful when such antagonism is...
|
|
|
5591756 |
LTB4 synthesis inhibitors
This invention relates to a compound of the formula: ##STR1## or a pharmaceutically acceptable salt thereof wherein X is oxygen, sulfur, --CHCH--, or --CHN--; wherein R 1 is --CO 2 R 2 ...
|
|
|
5559134 |
Leukotriene-B.sub.4 antagonists, process for their production and their use as pharmaceutical agents
The invention relates to leukotriene-B 4 antagonists of formula I ##STR1## in which n represents a whole number from 2 to 5, X represents a direct bond, 1 to 6 methylene units, an ortho-, meta-...
|
|
|
5534635 |
Process for preparing pyridine-2-carboxamides
It has been found that pyridine-2-carboxamides of the formula ##STR1## wherein R is amino or a residue convertible into amino, and pharmaceutically usable acid addition salts of that carboxamide in...
|
|
|
5527921 |
Peroxycarboxylic ester initiators derived from nitrogen heterocycles
Peroxycarboxylic ester photoinitiators derived from aromatic nitrogen containing heterocyclic carboxylic acids are described. The heterocyclic aromatic ring may contain additional nitrogen atoms,...
|
|
|
5520828 |
Fabric conditioners derived from pyridine carboxylic acids
Novel fabric conditioners based on pyridine carboxylic acid esters or amides are described. The compounds are effective fabric conditioners and are biodegradable. Compositions including the...
|
|
|
5508293 |
Pyridinecarboxyimidamide compounds and the use thereof
Disclosed are pyridinecarboximidamides having a vasodilating effect (hypotensive activity or antianginal activity), and acid adduct salts thereof. ##STR1## wherein when R 1 represents an alkyl,...
|